Latest News for: congruence

Edit

Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area

PR Newswire 06 Dec 2024
Osaka, Japan; President. Toichi Takino; "Ono") announced that it has entered into a drug discovery collaboration agreement with Congruence Therapeutics (Headquarters ... About Congruence Therapeutics.
Edit

Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area (ONO Pharmaceutical Co Ltd)

Public Technologies 03 Dec 2024
Toichi Takino; "Ono") announced that it has entered into a drug discovery collaboration agreement with Congruence Therapeutics (Headquarters ... Congruence will be ... About Congruence Therapeutics.
Edit

Congruence and Ono Announce Multi-Target Research Collaboration to Generate Small Molecule Correctors for the Treatment of Cancer

PR Newswire 03 Dec 2024
Collaboration leverages Congruence's proprietary drug discovery engine, Revenir™. Congruence to receive an undisclosed upfront payment and is eligible to receive milestones and royalties ... About Congruence Therapeutics.
Edit

Congruence among Egypt, Sudan on water security stance: Foreign Ministry

Egypt Today 07 Nov 2024
There was also congruence among the two ministers on the stance pertaining to water security, as both underscored that it is a matter of existence that cannot be ...
Edit

Congruence Therapeutics Announces Blitz Talk Award And Poster Presentations On MC4R-Deficient Genetic Obesity Program At ...

MENA FN 03 Nov 2024
(MENAFN - PR Newswire). - Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - - ... .
Edit

Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R-Deficient Genetic Obesity Program at Obesity Week 2024

PR Newswire 03 Nov 2024
- Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - ... Tunde Golenar, PhD, Principal Scientist, Biology, Congruence TherapeuticsLocation.
Edit

Congruence Therapeutics Announces Poster Presentation On Discovery Of Novel Gcase Correctors For Parkinson's Disease With ...

MENA FN 27 Sep 2024
(MENAFN - PR Newswire). - Congruence's RevenirTM drug discovery engine identified diverse correctors of GCase designed to target the key biological dysfunction in Parkinson's disease patients with ... .
Edit

Congruence Therapeutics Announces Poster Presentation on Discovery of Novel GCase Correctors for Parkinson's Disease with GBA1 Mutations at the 2024 International Congress of Parkinson's Disease and Movement Disorders Meeting

PR Newswire 27 Sep 2024
- Congruence's Revenir™ drug discovery engine identified diverse correctors of GCase designed to target the key biological dysfunction in Parkinson's disease patients with GBA1 mutations - ... About Congruence Therapeutics.
Edit

OpenFold AI Research Consortium Welcomes Six New Members: Astex, Biogen, Congruence, Polaris Quantum, Psivant, and SandboxAQ

Business Wire 13 Aug 2024
DAVIS, Calif.--(BUSINESS WIRE)--The non-profit consortium is developing publicly accessible advanced AI-based drug discovery software tools ... .
Edit

OLAW Webinar Available: Congruence Review (NIH - National Institutes of Health)

Public Technologies 15 May 2024
). The text version of this document is not available ... Disclaimer ... (noodl. 117790019) .
Edit

Congruence Therapeutics Appoints Experienced Drug Developer Michael D. Harvey, Ph.D. as Chief Development Officer

PR Newswire 06 May 2024
"I am pleased to join forces with Clarissa following our successful experience at Clementia, and starting my new role on the accomplished Congruence management team.  Congruence's computational ...

Most Viewed

×